Yeah ... a BP partner seems almost inevitable. Unless the FDA offers a path to an NDA now, but even then I think a BP is inevitable unless Hepalink could/would pick up the ball for maunfacturing, sales, distribution. 

Along with foreshadowing good "data data data" Don seems to be foreshadowing more potentially, in partnerships. Hopefully, the data is good enough to either move forward now, or attract a strong partner at good terms for RVX (and the investors) in the short term. JMHO.